Xencor (NASDAQ:XNCR) Issues Earnings Results

Xencor (NASDAQ:XNCR – Get Free Report) released its earnings results on Tuesday. The biopharmaceutical company reported ($0.40) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.77) by $0.37, Briefing.com reports. Xencor had a negative net margin of 81.94% and a negative return on equity of 17.26%. The company had revenue of […]

Leave a Reply

Your email address will not be published.

Previous post Verve Therapeutics (NASDAQ:VERV) Announces Earnings Results
Next post Natwest clears former chief Alison Rose of misconduct in Farage debanking row